Christopher Ogden

Date	Company	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
20 Aug 24	CTMX CytomX Therapeutics	Common Stock	Sell	Dispose S	No	No	1.2291	1,984	2.44 k	108,077
20 Aug 24	CTMX CytomX Therapeutics	Common Stock	Option exercise	Acquire M	No	No	0	6,875	0.00	110,061
20 Aug 24	CTMX CytomX Therapeutics	Performance Stock Units (PSUs) Common Stock	Option exercise	Dispose M	No	No	0	6,875	0.00	0
12 Jun 24	CTMX CytomX Therapeutics	Common Stock	Grant	Acquire A	No	No	0	17,500	0.00	103,186
12 Jun 24	CTMX CytomX Therapeutics	Stock Option Common Stock	Grant	Acquire A	No	No	1.49	75,000	111.75 k	75,000
19 Mar 24	CTMX CytomX Therapeutics	Common Stock	Sell	Dispose S	No	No	2.0855	2,971	6.20 k	85,686
18 Jan 24	CTMX CytomX Therapeutics	Common Stock	Grant	Acquire A	No	No	0	40,000	0.00	88,657
18 Jan 24	CTMX CytomX Therapeutics	Performance Stock Units (PSUs) Common Stock	Grant	Acquire A	No	No	0	75,000	0.00	75,000
18 Jan 24	CTMX CytomX Therapeutics	Stock Option Common Stock	Grant	Acquire A	No	No	1.68	154,000	258.72 k	154,000
20 Dec 23	CTMX CytomX Therapeutics	Common Stock	Sell	Dispose S	No	No	1.3806	1,990	2.75 k	48,657

Data from 3, 4 and 5 filings. Values as filed, not updated for current price.